The Efficacy of Amrubicin Therapy as a Second Line Treatment in Patients with Small Cell Carcinoma of the Prostate : A Case Report
A 68-year-old man was diagnosed with prostate cancer (initial serum prostate specific antigen [PSA] 389 ng/ml, stage cT4N1M1c, Gleason score 5+4), and androgen deprivation therapy was initiated. Despite the low serum PSA level, he developed postrenal acute kidney failure 4 years later, with progress...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 66(2020), 4 vom: 26. Apr., Seite 121-125
|
|---|
| 1. Verfasser: |
Ozawa, Kaori
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Yuhara, Kazuya,
Kotaka, Hiroto,
Kato, Daiki,
Takai, Manabu,
Iinuma, Koji,
Nakane, Keita,
Okamoto, Kiyohisa,
Koie, Takuya |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Japanese |
|---|
| Veröffentlicht: |
2020
|
|---|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Schlagworte: | Case Reports
Journal Article
Androgen Antagonists
Anthracyclines
amrubicin
93N13LB4Z2
Prostate-Specific Antigen
EC 3.4.21.77 |
|---|